HomeCompareHRPMF vs PEP

HRPMF vs PEP: Dividend Comparison 2026

HRPMF yields 56.98% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRPMF wins by $419.3K in total portfolio value
10 years
HRPMF
HRPMF
● Live price
56.98%
Share price
$3.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$561.2K
Annual income
$126,052.94
Full HRPMF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — HRPMF vs PEP

📍 HRPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRPMFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRPMF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRPMF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF
Annual income on $10K today (after 15% tax)
$4,843.30/yr
After 10yr DRIP, annual income (after tax)
$107,145.00/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, HRPMF beats the other by $54,550.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + PEP for your $10,000?

HRPMF: 50%PEP: 50%
100% PEP50/50100% HRPMF
Portfolio after 10yr
$351.6K
Annual income
$93,964.31/yr
Blended yield
26.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

HRPMF
No analyst data
Altman Z
-40.5
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys
0
PEP buys
0
No recent congressional trades found for HRPMF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRPMFPEP
Forward yield56.98%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$561.2K$141.9K
Annual income after 10y$126,052.94$61,875.67
Total dividends collected$460.7K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HRPMF vs PEP ($10,000, DRIP)

YearHRPMF PortfolioHRPMF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$16,398$5,698.01$10,849$509.42+$5.5KHRPMF
2$26,278$8,732.33$11,969$750.47+$14.3KHRPMF
3$41,196$13,078.29$13,500$1,124.14+$27.7KHRPMF
4$63,241$19,161.35$15,680$1,721.66+$47.6KHRPMF
5$95,159$27,490.76$18,929$2,715.34+$76.2KHRPMF
6$140,479$38,659.15$24,023$4,450.80+$116.5KHRPMF
7$203,650$53,337.34$32,510$7,669.92+$171.1KHRPMF
8$290,169$72,263.73$47,709$14,093.60+$242.5KHRPMF
9$406,709$96,228.48$77,415$28,083.48+$329.3KHRPMF
10$561,232$126,052.94$141,922$61,875.67+$419.3KHRPMF

HRPMF vs PEP: Complete Analysis 2026

HRPMFStock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this HRPMF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHDHRPMF vs JEPIHRPMF vs OHRPMF vs KOHRPMF vs MAINHRPMF vs MOHRPMF vs PMHRPMF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.